Boji Medical Technology Co.,Ltd. (SHE:300404)
China flag China · Delayed Price · Currency is CNY
12.68
-0.29 (-2.24%)
At close: Sep 2, 2026

Boji Medical Technology Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
951.16851.18723.92541.59411.06314.65
Other Revenue
10.1717.4618.114.2412.629.55
961.34868.64742.02555.83423.68324.2
Revenue Growth
26.15%17.07%33.50%31.19%30.69%24.47%
Cost of Revenue
722.5636.41517.98373.34267.57185.56
Gross Profit
238.84232.23224.04182.49156.11138.64
Selling, General & Admin
118.58123.56124.44108.9988.6571.19
Research & Development
57.8257.562.5954.9743.6827.65
Other Operating Expenses
6.997.246.623.242.82.27
Operating Expenses
196.83214.73214.03182.56150.05109.43
Operating Income
42.0117.510-0.076.0629.22
Interest Expense
-0.77-1.68-3.19-1.53-0.7-1.41
Interest & Investment Income
13.031.674.284.333.644.21
Currency Exchange Gain (Loss)
0.070.070-0.01-0.01-0.01
Other Non Operating Income (Expenses)
-10.37-0.5-2.34-0.59-0.41-0.4
EBT Excluding Unusual Items
43.9717.068.762.128.5831.61
Gain (Loss) on Sale of Investments
2.311.481.060.591.79-
Gain (Loss) on Sale of Assets
-0--0.210--
Asset Writedown
-0.25-0.01-0.08-0.03-0.07-0.3
Other Unusual Items
10.4411.528.8914.9514.2715.78
Pretax Income
56.4730.0618.4217.6324.5747.09
Income Tax Expense
3.37-2.85-12.24-9.56-4.743.59
Earnings From Continuing Operations
53.132.9130.6627.1929.3143.5
Minority Interest in Earnings
-0.97-2.42-1.88-2.85-1.64-4.62
Net Income
52.1230.4928.7824.3427.6738.88
Net Income to Common
52.1230.4928.7824.3427.6738.88
Net Income Growth
266.78%5.97%18.23%-12.04%-28.84%128.87%
Shares Outstanding (Basic)
384384382370367349
Shares Outstanding (Diluted)
384384383371367349
Shares Change
0.26%0.36%3.14%0.97%5.18%10.02%
EPS (Basic)
0.140.080.080.070.080.11
EPS (Diluted)
0.140.080.080.070.080.11
EPS Growth
265.84%5.58%14.63%-12.88%-32.34%108.04%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
53.568.3-2.57-26.24-89.59-23.89
Free Cash Flow Per Share
0.140.18-0.01-0.07-0.24-0.07
Dividend Per Share
0.0130.0130.0120.0100.0100.014
Dividend Growth
8.33%8.33%20.00%0%-30.07%-
Gross Margin
24.84%26.73%30.19%32.83%36.85%42.77%
Operating Margin
4.37%2.02%1.35%-0.01%1.43%9.01%
Profit Margin
5.42%3.51%3.88%4.38%6.53%11.99%
Free Cash Flow Margin
5.56%7.86%-0.35%-4.72%-21.15%-7.37%
EBITDA
68.1343.1634.5320.424.9946.03
EBITDA Margin
7.09%4.97%4.65%3.67%5.90%14.20%
D&A For EBITDA
26.1225.6524.5220.4718.9316.81
EBIT
42.0117.510-0.076.0629.22
EBIT Margin
4.37%2.02%1.35%-0.01%1.43%9.01%
Effective Tax Rate
5.97%----7.62%
Revenue as Reported
507.2868.64742.02555.83423.68324.2
Advertising Expenses
-2.612.291.850.710.65